SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

DELHI HIGH COURT
C.HARI SHANKAR
Merck Sharp and Dohme Corp. – Appellant
Versus
YMS Laboratories Private Limited – Respondent


Table of Content
1. settlement terms regarding patent infringement. (Para 1 , 2 , 3)
2. court acknowledges mutual agreement. (Para 4 , 5 , 6)
3. decree and court fee refund granted. (Para 7 , 8)

JUDGMENT (ORAL)

C. Hari Shankar, J.

I.A. 21336/2022(Order XXIII Rule 3 of the CPC)

1. The dispute between the plaintiffs and the defendant stands settled mutually.

2. This application under Order XXIII Rule 3 of the Code of Civil Procedure, 1908 (CPC) seeks that the suit be decreed in terms of the said settlement.

3. The terms of settlement, as set out in para 2 of the application may be reproduced, thus:

    "(i) The Parties have agreed that the Commercial Suit for Patent Infringement, being C.S.(Comm) 250 of 2021 shall be decreed by the Hon'ble High Court of Delhi, in terms of the present settlement agreement.

    (ii) The Defendant acknowledges the validity of the suit patent IN 209816 and the Plaintiff No. 1's exclusive right in dealing in Sitagliptin or any of its pharmaceutically acceptable salts, as an Active Pharmaceutical Ingredient (hereinafter referred as `API') including Sitagliptin Phosphate Mono-hydrate, as an impurity, finished product or any of its pharmaceutically acceptable salt

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top